Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

VRTX Cash From Financing

Annual CFF

-$2.26B$766.40M-51.27%

Summary

Current Value
As of today, VRTX annual cash from financing is -$2.26B, down -51.27% on
Historical Performance
VRTX annual cash from financing is down -3240.18% over the past 3 years, down -347.53% over the past 5 years
All-Time High Comparison
VRTX annual cash from financing is currently -326.35% below its historical high of $999.01M set on
3-Year Low Comparison
VRTX annual cash from financing is at its 3-year low
Sector Comparison
VRTX annual cash from financing is higher than 2.15% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRTX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing-$2.26B-51.3%-3240.2%-347.5%-632.0%
Quarterly Cash From Financing-$77.20M+80.3%-292.0%+38.3%-917.2%
TTM Cash From Financing-$2.26B-51.3%-3240.2%-347.5%-632.0%
Price$483.05+0.6%+68.1%+126.8%+977.3%
Annual Cash From Operations$3.63B+837.2%-12.1%+11.6%+671.5%
Annual Cash From Investing-$945.40M+74.9%-194.4%-1051.2%-10000.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$2.04B+16.4%+126.3%+116.0%+279.1%
Shares Outstanding256.39M-0.2%-0.3%-1.4%

Cash From Financing Highs

VRTX Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y-$67.70MN/A-3240.2%
5Y-$67.70M-3240.2%
All$999.01M-326.4%

Cash From Financing Lows

VRTX Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$2.26Bat low
5Y-$2.26Bat low
All-$2.26Bat low

Cash From Financing History

YearValueChange
-$2.26B-51.3%
-$1.49B-165.9%
-$562.20M-730.4%
-$67.70M+95.4%
-$1.48B-192.5%
-$505.28M-498.6%
$126.77M+278.0%
-$71.22M-204.1%
$68.40M-48.7%
$133.27M-29.5%
$188.92M-62.0%
$497.38M+175.0%
$180.88M+5.0%
$172.20M+238.6%
-$124.24M-129.2%
$425.06M-57.5%
$999.01M+60.9%
$620.74M+6,191.6%
YearValueChange
-$10.19M-102.8%
$365.87M+85.3%
$197.47M+2,389.3%
-$8.63M-123.0%
$37.47M+170.7%
$13.84M+447.6%
-$3.98M-100.7%
$544.03M>+9,900.0%
$2.78M-33.4%
$4.16M-97.5%
$164.79M+89.3%
$87.05M+4,978.8%
$1.71M-97.6%
$71.85M+4,343.7%
$1.62M+232.5%
-$1.22M-102.4%
$50.91M-

FAQ

  • What is the current annual cash from financing of VRTX?

    As of today, VRTX annual cash from financing is -$2.26B

  • What is 1-year change in VRTX annual cash from financing?

    VRTX annual cash from financing is down -51.27% year-over-year

  • What is 3-year change in VRTX annual cash from financing?

    VRTX annual cash from financing is down -3240.18% over the past 3 years

  • How far is VRTX annual cash from financing from its all-time high?

    VRTX annual cash from financing is currently -326.35% below its historical high of $999.01M set on December 31, 2009

  • How does VRTX annual cash from financing rank versus sector peers?

    VRTX annual cash from financing is higher than 2.15% of companies in Healthcare sector

  • When is VRTX next annual earnings release?

    As of today, the next annual earnings release for VRTX has not been scheduled

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
  4. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  5. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx